Bio, I share your view about Sygenus potential. It would be good if we could get a status report on where things are up to with: - commercialising the acne treatment; - the Adelaide Uni/Macquarie Uni follow up to the Israeli study findings on use of Sygenus for pain management; - current and planned studies into use of Sygenus for other specific medical/dermatological conditions.
i can’t see that there would be a commercial need for the company to be a secret squirrel about any of those 3 things.
zeno9
RGS Price at posting:
13.0¢ Sentiment: Buy Disclosure: Held
